Profile
Ruben Tommasi is currently the Chief Scientific Officer at Entasis Therapeutics, Inc. and Entasis Therapeutics Holdings, Inc. He previously worked as the Executive Director-Chemistry at AstraZeneca AB and as the Head-Infection Chemistry Unit at Novartis Institutes for Biomedical Research, Inc. Dr. Tommasi received his undergraduate and doctorate degrees from the State University of New York at Albany.
Ruben Tommasi active positions
| Companies | Position | Start |
|---|---|---|
| ENTASIS THERAPEUTICS HOLDINGS INC. | Chief Tech/Sci/R&D Officer | 30/04/2015 |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Chief Tech/Sci/R&D Officer | 30/04/2015 |
Former positions of Ruben Tommasi
| Companies | Position | End |
|---|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | 30/04/2015 |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 31/03/2011 |
Training of Ruben Tommasi
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
State University of New York at Albany
State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Health Technology |
Entasis Therapeutics Holdings, Inc.
Entasis Therapeutics Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biopharmaceutical company that engages in development of antibacterial products | Commercial Services |
- Stock Market
- Insiders
- Ruben Tommasi
















